455 Mission Bay Blvd South
San Francisco, CA 94158
Nektar Therapeutics is a research-based biopharmaceutical company whose mission is to discover and develop innovative medicines to address the unmet medical needs of patients. Their wholly-owned R&D pipeline of new investigational medicines includes treatments for cancer, auto-immune disease and chronic pain. Nektar Therapeutics also has a number of strategic partnerships ranging from joint discovery and co-development to licensing and royalty arrangements with various companies. Nektar Therapeutics leverages their proprietary and proven chemistry platform in the discovery and design of their new therapeutic candidates. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India.
Clinical Development Stage
Approved; Clinical; PreClinical